342 related articles for article (PubMed ID: 3034598)
1. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.
Kraus MH; Popescu NC; Amsbaugh SC; King CR
EMBO J; 1987 Mar; 6(3):605-10. PubMed ID: 3034598
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
3. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.
Hollywood DP; Hurst HC
EMBO J; 1993 Jun; 12(6):2369-75. PubMed ID: 8099545
[TBL] [Abstract][Full Text] [Related]
4. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.
Yamazaki H; Fukui Y; Ueyama Y; Tamaoki N; Kawamoto T; Taniguchi S; Shibuya M
Mol Cell Biol; 1988 Apr; 8(4):1816-20. PubMed ID: 3380099
[TBL] [Abstract][Full Text] [Related]
7. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
Lacroix H; Iglehart JD; Skinner MA; Kraus MH
Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
10. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe.
Joos S; Scherthan H; Speicher MR; Schlegel J; Cremer T; Lichter P
Hum Genet; 1993 Feb; 90(6):584-9. PubMed ID: 8383093
[TBL] [Abstract][Full Text] [Related]
11. Unique chromosomal location of amplified EGF receptor genes in EGF receptor-hyperproducing tumor cell line NA.
Gamou S; Kobayashi M; Furusho T; Shimizu N
Somat Cell Mol Genet; 1989 Mar; 15(2):179-84. PubMed ID: 2928843
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
13. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Semba K; Kamata N; Toyoshima K; Yamamoto T
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
[TBL] [Abstract][Full Text] [Related]
14. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
16. Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.
Haley JD; Waterfield MD
J Biol Chem; 1991 Jan; 266(3):1746-53. PubMed ID: 1988448
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 DNA amplification and mRNA expression in human primary breast tumors and its relationship to other prognostic factors.
Nagai MA; Pacheco MM; Oshima CT; Brentani MM
Cancer Biother; 1993; 8(1):29-35. PubMed ID: 7812345
[TBL] [Abstract][Full Text] [Related]
18. Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
King CR; Kraus MH; Aaronson SA
Science; 1985 Sep; 229(4717):974-6. PubMed ID: 2992089
[TBL] [Abstract][Full Text] [Related]
19. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
King CR; Borrello I; Bellot F; Comoglio P; Schlessinger J
EMBO J; 1988 Jun; 7(6):1647-51. PubMed ID: 2901952
[TBL] [Abstract][Full Text] [Related]
20. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
